Author:
Triguero A.,Xicoy B.,Zamora L.,Jiménez MJ.,García O.,Calabuig M.,Díaz-Beyá M.,Arzuaga J.,Ramos F.,Medina A.,Bernal T.,Talarn C.,Coll R.,Collado R.,Chen T.Hua,Borrás J.,Brunet S.,Marchante I.,Marco V.,López-Cadenas F.,Calbacho M.,Simiele A.,Cortés M.,Cedena MT.,Pedreño M.,Aguilar C.,Pedró C.,Fernández M.,Stoica C.,Ribera JM.,Sanz G.
Funder
Agència de Gestió d'Ajuts Universitaris i de Recerca
Gutenberg Forschungskolleg
Generalitat de Catalunya
Subject
Cancer Research,Oncology,Hematology
Reference30 articles.
1. Current management of patients with chronic myelomonocytic leukemia;Mora;Curr. Opin. Oncol.,2018
2. Diagnosis and treatment of chronic myelomonocytic leukemias in adults;Itzykson;HemaSphere,2018
3. How I treat chronic myelomonocytic leukemia;Solary;Blood,2017
4. Swerdlow SH, Campo E., Harris NL, Jaffe ES, Pileri SA, Stein HTJ. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition. 4th ed. IARC, editor. 2017.
5. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br. J. Haematol.,1982